LEOCLANLtd Past Earnings Performance

Past criteria checks 0/6

LEOCLANLtd's earnings have been declining at an average annual rate of -18.4%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been declining at an average rate of 3.5% per year. LEOCLANLtd's return on equity is 2.7%, and it has net margins of 0.7%.

Key information

-18.4%

Earnings growth rate

-14.3%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate-3.5%
Return on equity2.7%
Net Margin0.7%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

LEOCLANLtd (TSE:7681) Might Be Having Difficulty Using Its Capital Effectively

Dec 23
LEOCLANLtd (TSE:7681) Might Be Having Difficulty Using Its Capital Effectively

Revenue & Expenses Breakdown

How LEOCLANLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:7681 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2419,8041362,4400
30 Jun 2425,6712662,4540
31 Mar 2427,1863482,4430
31 Dec 2327,1093752,4130
30 Sep 2326,6322712,3780
30 Jun 2321,24672,4110
31 Mar 2322,673352,4070
31 Dec 2224,025252,4290
30 Sep 2229,7674372,4040
30 Jun 2230,0704752,3430
31 Mar 2228,2253472,2730
31 Dec 2129,0545132,1790
30 Sep 2126,3473902,1560
30 Jun 2127,7446642,0720
31 Mar 2126,5346642,0370
31 Dec 2023,7593792,0540
30 Sep 2021,9961202,0510
30 Jun 2023,585132,1230
30 Sep 1936,1097322,1570
30 Sep 1825,7153572,0430
30 Sep 1719,0602421,9240

Quality Earnings: 7681 has a high level of non-cash earnings.

Growing Profit Margin: 7681's current net profit margins (0.7%) are lower than last year (1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7681's earnings have declined by 18.4% per year over the past 5 years.

Accelerating Growth: 7681's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 7681 had negative earnings growth (-49.8%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).


Return on Equity

High ROE: 7681's Return on Equity (2.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 03:36
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LEOCLAN Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keita FujinoThe Stock Research Center